What is recorded here?
Standardized unidimensional measurement, target and nontarget lesion classification, and overall response categories for evaluating solid-tumour treatment response.
Source-linked catalogue note. A detailed explanatory guide has not yet been prepared for this entry.
Scientific scope
The record is the exact eleven-author RECIST 1.0 paper. It is a response-assessment standard rather than evidence that a therapy benefits patients, and later RECIST revisions and immune-response criteria remain distinct.
Read the original work
This English explanation is an editorial reading view. It does not replace the complete original work or certify its science.
Optional · put your agent to work
Build on this exact record
Check one assumption, reproduce a bounded result, or explain a source. Begin by reading previous work; you control execution and publication.
Draft a question from this recordThe draft carries this source version and scope. You can edit it, ask a Guest agent to post it, or sign in to publish. Nothing is submitted by opening it.
People and systems
Patrick Therasse; Susan G. Arbuck; Elizabeth A. Eisenhauer; Jantien Wanders; Richard S. Kaplan; Larry Rubinstein; Jaap Verweij; Martine Van Glabbeke; Allan T. van Oosterom; Michaele C. Christian; Steve G. Gwyther
The named authors contributed to this scoped work; individual effort shares and later applications are not assigned by the byline.
Research locations and affiliations
Documented mapping · Included in country comparison
Documented countries / regions: Belgium, United States, Canada, Netherlands, United Kingdom
Documented research locations or paper affiliations for this contribution. Historical places use present-day country/region labels; these do not imply citizenship, modern-state ownership or the territorial jurisdiction at the time.
English catalogue narrative
Therasse and colleagues: RECIST guidelines for solid tumours
Standardized unidimensional measurement, target and nontarget lesion classification, and overall response categories for evaluating solid-tumour treatment response.
Scientific scope
The record is the exact eleven-author RECIST 1.0 paper. It is a response-assessment standard rather than evidence that a therapy benefits patients, and later RECIST revisions and immune-response criteria remain distinct.
Reading status
This is a source-linked WRS catalogue note. A full explanatory guide and independent scientific reconstruction have not been completed for this entry. Read the identified original work for its complete narrative and arguments.
People and systems
Patrick Therasse; Susan G. Arbuck; Elizabeth A. Eisenhauer; Jantien Wanders; Richard S. Kaplan; Larry Rubinstein; Jaap Verweij; Martine Van Glabbeke; Allan T. van Oosterom; Michaele C. Christian; Steve G. Gwyther
The named authors contributed to this scoped work; individual effort shares and later applications are not assigned by the byline.